Our Chief Operating Officer / Chief Strategy Officer, Karen Wen, Ph.D. will be a featured speaker at the Cell Therapy Manufacturing Asia meeting in Kyoto, Japan […]

Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D., present our prominent research in non-viral CAR-T therapy in “The Advanced Immuno-Oncology Forum” in Taipei on […]

Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D., gave a talk to share the opportunities and challenges of CAR-T in gene and cell therapy […]

Our EVP/COO & CTO, Dr. Chien-Tsun Kuan, hosted a session- Cell & gene therapy with six distinguished speakers sharing about their experiences in Bio-Asia Taiwan on […]

Our EVP., CTO/COOEVP/ COO and CTO, Dr. Chien-Tsun Kuan, delivered a company presentation in BIO-Asia, on July 25, 2019. This presentation received lots of attention.

Our Chief strategy & Product development Officer, Karen Wen, Ph.D. gave a company presentation in Taiwan Chamber of Commerce of New England (TCCNE) and shared with […]

Our EVP/ COO and CTO, Dr. Chien-Tsun Kuan, Ph.D. gave a company presentation in Boston Chinese Investment Club (BCIC), USA on June 23, 2019. This presentation […]

Our EVP/COO & CTO, Dr. Chien-Tsun Kuan, gave the presentation “Adoptive Cell Therapy CAR-T Cell Therapy” in Post-SITC conference in New Taipei City, Taiwan on March […]

Our EVP/COO & CTO, Dr. Chien-Tsun Kuan, gave the presentation “CAR-T Cell Therapy Development for Solid Tumor Treatment-Challenges & Opportunities” in BioProcess International Asia/Cell Therapy Manufacturing […]